| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $555.1M | — |
| Cost of Revenue | $152.0M | — |
| R&D Expense | $69.8M | — |
| SG&A Expense | $109.6M | — |
| Operating Income | -$804.1M | — |
| Interest Expense | $53.5M | — |
| Pre-tax Income | -$831.0M | — |
| Income Tax | -$41.0M | — |
| Net Income | -$725.0M | — |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $170.4M | +10.1% |
| Accounts Receivable | $183.6M | -13.6% |
| Current Assets | $405.7M | -5.0% |
| Total Assets | $1.64B | -26.1% |
| Current Liabilities | $425.1M | -22.1% |
| Long-term Debt | $581.8M | +25.9% |
| Stockholders' Equity | $531.8M | -49.8% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.9M | — |
| Capital Expenditures | $4.9M | — |
| Investing Cash Flow | -$42.2M | — |
| Financing Cash Flow | $77.2M | — |
| Free Cash Flow | -$25.8M | — |
| EPS (Basic) | -$4.56 | — |